In case you missed it, AEI health expert Scott Gottlieb, MD explains the transformation of the pharmaceutical industry in a recently published piece (full text below). Drug discovery has become targeted, averse to bureaucracy, and focused on solving more difficult to cure, serious maladies.

Key quote:
"Drug makers are renewing themselves by realizing that their research success wasn't tied to the scale of those endeavors, but their precision. Today, the continuation of these scientific advances depends on their regulators reaching a similar understanding"

Scott Gottlieb is a practicing physician and resident fellow at the American Enterprise Institute. He was deputy commissioner of the FDA and a senior adviser at the Centers for Medicare and Medicaid Services. He can be reached at scott.gottlieb@aei.org.

For help reaching any AEI scholars and for all other media requests, please contact Jesse Blumenthal at jesse.blumenthal@aei.org.

AEI's in-house ReadyCam TV studio may be booked by calling VideoLink at 617.340.4300. For radio interviews, please e-mail jesse.blumenthal@aei.org.